O

Outlook Therapeutics

Biotechnology📍 Iselin, NJ

Outlook Therapeutics is a late clinical-stage biopharmaceutical company developing ONS-5010/LYTENAVA™ (bevacizumab-vikg) for ophthalmic indications.

Visit website →View careers page →

Open Positions at Outlook Therapeutics

0 positions available

No open positions at the moment

Check back later for new opportunities!